Entrenching best-in-class ABX, alliance focuses on driving U.S. market growth for LG B2B display and IT solutions business BETHESDA, Md.–(BUSINESS WIRE)–MarketbridgeEntrenching best-in-class ABX, alliance focuses on driving U.S. market growth for LG B2B display and IT solutions business BETHESDA, Md.–(BUSINESS WIRE)–Marketbridge

Marketbridge Appointed as AOR by LG’s U.S. Commercial Display Division

2026/02/10 22:04
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Entrenching best-in-class ABX, alliance focuses on driving U.S. market growth for LG B2B display and IT solutions business

BETHESDA, Md.–(BUSINESS WIRE)–Marketbridge, the Go-to-Market® growth firm, today announced it has been named B2B Agency of Record (AOR) by the Commercial Display and IT Solutions division of LG Electronics USA.

A global leader in consumer electronics and home appliances, LG Electronics is also a formidable player in commercial displays as part of its worldwide business-to-business (B2B) strategy. In the United States, LG serves organizations ranging from small businesses to large enterprises across multiple industries through a broad and innovative portfolio of commercial displays, IT infrastructure, and software solutions.

LG selected Marketbridge as its U.S. commercial display business AOR after a competitive search process. “At its heart, LG believes in innovation—and we wanted the same in our new B2B agency partner,” said Paul Vitellaro, LG Electronics USA’s Head of B2B Marketing Communications, Campaigns and Branding. “Marketbridge distinguished itself through its modern B2B marketing capabilities and leadership in Account-Based Experiences (ABX), and the smart, inquisitive and collaborative nature of the team we met through the search process.”

Marketbridge also offers the breadth of B2B marketing capabilities that LG was seeking under one roof. Best-in-class go-to-market demand strategy, data and analytics, marketing operations support, media management and creative, among other services, are seamlessly integrated, providing clients with the opportunity to rationalize agency support without compromising quality.

“We are proud to have been selected by LG as its U.S. growth marketing partner for commercial displays and IT solutions. Applying our award-winning B2B and account-based marketing expertise to support the continued growth of one of the world’s most iconic brands represents an exciting strategic opportunity,” said Bob Ray, CEO of Marketbridge. “We look forward to a long-term partnership built on shared ambition and results.”

About Marketbridge
Marketbridge is the Go to Market® growth firm for sales and marketing leaders in complex markets. The firm helps enterprise organizations design, operationalize, activate, and measure modern go to market models through integrated strategy, insight, data orchestration, and activation. In the 2025 B2B Agencies Benchmarking Report, Marketbridge ranked number one in both Brand and Demand Agency categories and number two overall among the fastest growing U.S. B2B agencies.

About LG Electronics USA’s Commercial Displays and IT Solutions
LG Electronics USA serves commercial display and B2B IT customers in the U.S. lodging and hospitality, digital signage, systems integration, healthcare, education, government and industrial markets. Based in Lincolnshire, Ill., with its dedicated engineering and customer support team, LG’s U.S. Media Entertainment Solution B2B division delivers business-to-business technology solutions tailored to the particular needs of business environments. Eleven-time ENERGY STAR® Partner of the Year LG Electronics USA Inc., headquartered in Englewood Cliffs, N.J., is the North American subsidiary of LG Electronics Inc., a leading smart life solutions company with annual global revenues of more than $60 billion from consumer electronics, home appliances, HVAC solutions and vehicle components. For more information, please visit www.LGSolutions.com. Stay up to date with @LGforBusinessUSA on LinkedIn, Instagram, Facebook and YouTube.

Contacts

Gail Scibelli
gscibelli@marketbridge.com

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09